Berend Snijder
Berend Snijder is a system biologist at ETH Zürich, known for his innovative work in the field of precision medicine, particularly in developing an AI-based method called Pharmakoskopie. This technique analyzes biological samples from cancer patients to personalize treatment plans by determining how individual cells respond to various medications. His research aims to enhance treatment efficacy for cancer patients, especially those with aggressive forms of the disease, and represents a significant advancement towards tailored cancer therapies.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 8.00 | 0.10% | +0% | 8,654,622 | 8,742 | $700,000 | 707$ |
| Totals | 1 | 8,654,622 | 8,742 | $700,000 | 707$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Berend Snijder is leading a research group at ETH Zurich that has developed an AI-based method for analyzing biological samples from cancer patients.
8